• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
2 Minute Medicine
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
SUBSCRIBE
2 Minute Medicine
Subscribe
Home All Specialties Chronic Disease

Key characteristics of high mitotic rate melanoma elucidated

byShirin BajajandAdam Whittington
August 25, 2014
in Chronic Disease, Dermatology, Oncology
Reading Time: 2 mins read
0
Share on FacebookShare on Twitter

1. High mitotic rate melanoma was clinically more likely to present in elderly male patients, and more frequently presented as a rapidly growing lesion on the head and neck that may be amelanotic.                                            

2. High mitotic rate melanomas were associated with thick and ulcerated nodular tumor subtypes and therefore were associated with a more aggressive histopathologic subtype. 

Evidence Rating Level: 3 (Average) 

Study Rundown: Mitotic rate, a marker of cell proliferation, has been previously associated with decreased disease-free survival in patients with melanoma. However, its clinicopathologic associations have not been well established.  The authors of this study sought to identify characteristics associated with high mitotic rate melanoma, with the ultimate objective to aid earlier detection of these aggressive tumors. High mitotic rate melanoma was clinically associated with a distinct phenotype including rapidly growing lesions, amelanosis, age ≥70, male gender and location on the head and neck. Low mitotic rate was associated with family history of melanoma and history of blistering sunburns. The study had a large cohort, but was limited in its retrospective study design. Future studies are necessary to explore implications for earlier detection and better management of patients with this aggressive tumor type.

Click to read the study in JAMA Dermatology

Relevant Reading: Prognostic Significance of Mitotic Rate in Localized Primary Cutaneous Melanoma

RELATED REPORTS

BRAFV600-mutant ctDNA as a Prognostic Biomarker in Resected Stage III Melanoma

Ipilimumab/Nivolumab versus Nivolumab in Melanoma Brain Metastases

Neoadjuvant ipilimumab plus nivolumab improves event-free survival in stage III melanoma

In-Depth [case-control]: 1441 patients who had 1500 primary invasive melanomas between 2006-2011 were retrospectively selected for the study from the Victorian Melanoma Service medical record.  Demographic information, phenotypic markers, historical features, tumor presentation, and clinical exam information was obtained. Mitotic rate and histopathologic information was determined by two expert dermatopathologists. Mean mitotic rate was 2.8 mitoses/mm2. Univariate analysis showed that increasing mitotic rate was strongly associated with older age ≥70 (OR 2.1; 95% CI 1.7-2.8), male gender (OR 1.5; 95% CI 1.3-1.8), the presence of solar keratosis (OR 1.3; 95% CI, 1.1-1.6), and rate of growth (for rate of growth ≥2mm/mo, OR 14.6, 95%CI 10.0-21.2). Tumors of high mitotic rate were most likely to be found by the patients themselves, possibly due to the high growth rate. Multivariate analysis of histopathologic features revealed strong positive association of mitotic rate with nodular tumor type (OR 2.3; 95% CI 1.6-3.3, p<.001), ulceration (OR, 5.9; 95% CI, 3.0-11.7, P<.001), and thickness>5mm (OR 8.8; 95% CI, 4.9-15.9; P<.001).

More from this author: Tech-aided surveillance of patients at high risk for melanoma aids early diagnosis, Indoor tanning linked to high skin cancer risk in US and abroad, Free drug samples may alter prescription habits of dermatologists, Atopic dermatitis may be more persistent than previously understood 

Image: PD

©2012-2014 2minutemedicine.com. All rights reserved. No works may be reproduced without expressed written consent from 2minutemedicine.com. Disclaimer: We present factual information directly from peer reviewed medical journals. No post should be construed as medical advice and is not intended as such by the authors, editors, staff or by 2minutemedicine.com. 

Tags: melanoma
Previous Post

Severe acne linked to endometriosis

Next Post

Oral RSV entry inhibitor effective at reducing viral load and clinical symptoms

RelatedReports

Significant reduction in prostate screening rates after revised guidelines
Chronic Disease

BRAFV600-mutant ctDNA as a Prognostic Biomarker in Resected Stage III Melanoma

April 28, 2025
“No Evidence of Disease Activity” may be useful goal in multiple sclerosis
Chronic Disease

Ipilimumab/Nivolumab versus Nivolumab in Melanoma Brain Metastases

February 24, 2025
Increased risk of subsequent melanoma after first melanoma diagnosis
Dermatology

Neoadjuvant ipilimumab plus nivolumab improves event-free survival in stage III melanoma

December 12, 2024
Medicare beneficiaries have a lower rate of delayed melanoma surgeries
Chronic Disease

Adjuvant dabrafenib and trametinib improve survival in stage III melanoma

November 25, 2024
Next Post
Clinical practice guidelines linked to improved bronchiolitis outcomes

Oral RSV entry inhibitor effective at reducing viral load and clinical symptoms

Parental conceptions of weight are becoming increasingly inaccurate

Parental conceptions of weight are becoming increasingly inaccurate

AAP continues to recommend fluoride for prevention of dental caries

AAP continues to recommend fluoride for prevention of dental caries

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Seventh cervical nerve neurotomy may augment speech therapy in patients with chronic aphasia post-stroke
  • Time-restricted eating does not confer changes in sleep, mood, or quality of life
  • Commonly cited medication triggers may not increase risk of microscopic colitis among older adults
License Content
Terms of Use | Disclaimer
Cookie Policy
Privacy Statement (EU)
Disclaimer

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.

  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • AI Roundup
  • Pharma
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Visual
  • Podcasts
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • Sign-in
    • My account
No Result
View All Result

© 2021 2 Minute Medicine, Inc. - Physician-written medical news.